Biotech
Irish co-founded Ochre Bio signs $1.3bn deal with German drugmaker
Jack O’Meara’s Oxford based life-sciences company uses machine learning to develop RNA therapies for a range of chronic conditions
Ochre Bio, the biotech company founded by Irish man Jack O’Meara, has signed a $1.3 billion deal with a German drugmaker to investigate potential treatments for chronic liver disease.
The collaboration with Boehringer Ingelheim is focused on the discovery and development of novel, first-in-class regenerative treatments in conditions that include late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.
Co-founded by O’Meara and Quin Wills in Oxford in 2019, Ochre Bio uses breakthroughs in genomics and computation to ...
